NYSE:OGEN

Oragenics Stock Insider Trading

Healthcare > Biotechnology

Buy OGEN

*Your capital is at risk

$0.610

+0 (+0%)

At Close: Jun 03, 2026

Oragenics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 23.95. In total, the insiders bought 2.7M and sold 4.47M OGEN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	23.95
● Buy	2.7M shares
● Sell	4.47M shares
64% Buy Activity Moderate Negative Correlation
Buy Signal Medium Confidence May 26, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 23.95. Confidence increased due to high data reliability score of 90.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 06, 2024 Sell	Common Stock S-Sale	Telling Fred Director	Director	3 597 Value: $1K
Dec 06, 2024 Sell	Common Stock S-Sale	Telling Fred Director	Director	3 597 Value: $1K
Dec 06, 2024 Sell	Common Stock S-Sale	Dunton Alan W Director	Director	66 Value: $24
Sep 19, 2024 Buy	Employee Option (Right to Buy) A-Award	Huffman Janet Chief Financial Officer	C-Suite Officer	80 000 Value: $38.4K
Sep 19, 2024 Buy	Employee Option (Right to Buy) A-Award	Redmond J Michael President	CEO / President	100 000 Value: $48.0K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Pope Charles L Director	Director	100 000 Value: $48.0K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Gandolfo John P Director	Director	45 000 Value: $21.6K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Dunton Alan W Director	Director	65 000 Value: $31.2K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Koski Robert C Director	Director	65 000 Value: $31.2K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Cassidy Bruce A. Sr. Director	Director	45 000 Value: $21.6K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Murphy Kimberly M Director	Director	27 083 Value: $13.0K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Telling Fred Director	Director	65 000 Value: $31.2K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Telling Fred Director	Director	65 000 Value: $31.2K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Murphy Kimberly M Director	Director	27 083 Value: $13.0K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Cassidy Bruce A. Sr. Director	Director	45 000 Value: $21.6K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Koski Robert C Director	Director	65 000 Value: $31.2K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Dunton Alan W Director	Director	65 000 Value: $31.2K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Gandolfo John P Director	Director	45 000 Value: $21.6K
Sep 19, 2024 Buy	Non-Employee Director Option (Right to Buy) A-Award	Pope Charles L Director	Director	100 000 Value: $48.0K
Sep 19, 2024 Buy	Employee Option (Right to Buy) A-Award	Redmond J Michael President	CEO / President	100 000 Value: $48.0K
Sep 19, 2024 Buy	Employee Option (Right to Buy) A-Award	Huffman Janet Chief Financial Officer	C-Suite Officer	80 000 Value: $38.4K
Dec 31, 2023 Buy	Common Stock J-Other	Koski Robert C	Director	0 Value: $0
Dec 31, 2023 Buy	Common Stock J-Other	Koski Robert C	Director	0 Value: $0
Dec 28, 2023 Buy	Series F Preferred Stock	Odyssey Health, Inc. 10 Percent Owner	10% Owner	0 Value: $0
Dec 28, 2023 Buy	Common Stock	Odyssey Health, Inc. 10 Percent Owner	10% Owner	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ORAGENICS INC

Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also ...

Read Full Profile Here